Chemical Compound Review:
Lopac-E-114 (2S,3S)-3-(6-aminopurin-9- yl)nonan-2-ol
Synonyms:
CHEMBL1555103, AC1L3ZQR, (+/-)-EHNA, 51350-19-7, 59262-86-1, ...
- The role of transmethylation reactions in regulating the binding of BCG-activated murine macrophages to neoplastic target cells. Adams, D.O., Pike, M.C., Snyderman, R. J. Immunol. (1981)
- Cardioprotection with adenosine metabolism inhibitors in ischemic-reperfused mouse heart. Peart, J., Matherne, G.P., Cerniway, R.J., Headrick, J.P. Cardiovasc. Res. (2001)
- Endogenous adenosine reduces the occurrence of ischemia-induced ventricular fibrillation in rat heart. Schreieck, J., Richardt, G. J. Mol. Cell. Cardiol. (1999)
- Role of nucleoside transport and purine release in a rabbit model of myocardial stunning. Abd-Elfattah, A.S., Maddox, R.P., Jessen, M.E., Rebeyka, I.M., Wechsler, A.S. Mol. Cell. Biochem. (1998)
- Effect of a dynein inhibitor on vasopressin action in toad urinary bladder. Marples, D., Barber, B., Taylor, A. J. Physiol. (Lond.) (1996)
- Differential inhibition by erythro-9-[3-(2-hydroxynonyl)]adenine of flagella-like and cilia-like movement of Leishmania promastigotes. Alexander, J., Burns, R.G. Nature (1983)
- cGMP-stimulated cyclic nucleotide phosphodiesterase regulates the basal calcium current in human atrial myocytes. Rivet-Bastide, M., Vandecasteele, G., Hatem, S., Verde, I., Bénardeau, A., Mercadier, J.J., Fischmeister, R. J. Clin. Invest. (1997)
- erythro-9-[3-(2-Hydroxynonyl)]adenine is an effective inhibitor of cell motility and actin assembly. Schliwa, M., Ezzell, R.M., Euteneuer, U. Proc. Natl. Acad. Sci. U.S.A. (1984)
- Adenine nucleotides and ventricular fibrillation. Lubbe, W.F., Gilchrist, A.I., Holland, R.K., Pybus, J. J. Mol. Cell. Cardiol. (1987)
- Positive inotropic effect of the inhibition of cyclic GMP-stimulated 3',5'-cyclic nucleotide phosphodiesterase (PDE2) on guinea pig left atria in eu- and hyperthyroidism. Gesztelyi, R., Zsuga, J., Hajdú, P., Szabó, J.Z., Cseppento, A., Szentmiklósi, A.J. Gen. Physiol. Biophys. (2003)
- Mechanisms of apoptosis induced by purine nucleosides in astrocytes. Di Iorio, P., Kleywegt, S., Ciccarelli, R., Traversa, U., Andrew, C.M., Crocker, C.E., Werstiuk, E.S., Rathbone, M.P. Glia (2002)
- Inhibition of adenosine metabolism increases myocardial interstitial adenosine concentrations and coronary flow. Ely, S.W., Matherne, G.P., Coleman, S.D., Berne, R.M. J. Mol. Cell. Cardiol. (1992)
- 2'-Deoxy-2'-methylene derivatives of adenosine, guanosine, tubercidin, cytidine and uridine as inhibitors of L1210 cell growth in culture. Cory, A.H., Samano, V., Robins, M.J., Cory, J.G. Biochem. Pharmacol. (1994)
- The effect of G2-treatments with 2'-deoxyadenosine on the frequency of chromatid aberrations in human lymphocytes depends on the type of culture. Kihlman, B.A., Andersson, H.C. Chromosoma (1984)
- erythro-9-[3-(2-Hydroxynonyl)]adenine is an inhibitor of sperm motility that blocks dynein ATPase and protein carboxylmethylase activities. Bouchard, P., Penningroth, S.M., Cheung, A., Gagnon, C., Bardin, C.W. Proc. Natl. Acad. Sci. U.S.A. (1981)
- Relative sensitivity of human T cell subsets to deoxyadenosine toxicity. Callard, R.E., Ewing, T.M., Fox, R.M. Clin. Exp. Immunol. (1984)
- Endogenous adenosine facilitates neurotransmission via A2A adenosine receptors in the rat superior colliculus in vivo. Ishikawa, S., Saijoh, K., Okada, Y. Brain Res. (1997)
- Signalling events regulating the retrograde axonal transport of 125I-beta nerve growth factor in vivo. Reynolds, A.J., Bartlett, S.E., Hendry, I.A. Brain Res. (1998)
- Isolation and characterization of human cDNAs encoding a cGMP-stimulated 3',5'-cyclic nucleotide phosphodiesterase. Rosman, G.J., Martins, T.J., Sonnenburg, W.K., Beavo, J.A., Ferguson, K., Loughney, K. Gene (1997)
- An improved purification method for cytoplasmic dynein. Pratt, M.M., Hisanaga, S., Begg, D.A. J. Cell. Biochem. (1984)
- Modulation by presynaptic adenosine A1 receptors of nicotinic receptor antagonist-induced neuromuscular block in the mouse. Prior, C., Breadon, E.L., Lindsay, K.E. Eur. J. Pharmacol. (1997)
- Adenosine and deoxyadenosine induces apoptosis in oestrogen receptor-positive and -negative human breast cancer cells via the intrinsic pathway. Hashemi, M., Karami-Tehrani, F., Ghavami, S., Maddika, S., Los, M. Cell Prolif. (2005)
- Decreased 5'-nucleotidase activity in suppressor (OKT8) T lymphocytes from homosexuals with AIDS-related complex: nonassociation with enhanced deoxynucleoside toxicity. Murray, J.L., Bywaters, D.W., Reuben, J.M., Mansell, P.W., Hersh, E.M. Clin. Immunol. Immunopathol. (1987)
- Enhanced oral bioavailability of 2'- beta-fluoro-2',3'-dideoxyadenosine (F-ddA) through local inhibition of intestinal adenosine deaminase. DeGraw, R.T., Anderson, B.D. Pharm. Res. (2001)
- Adenosine deaminase activity in the serum and malignant tumors of breast cancer: the assessment of isoenzyme ADA1 and ADA2 activities. Aghaei, M., Karami-Tehrani, F., Salami, S., Atri, M. Clin. Biochem. (2005)
- Inhibition of adenosine deaminase from several sources by deaza derivatives of adenosine and EHNA. Lupidi, G., Cristalli, G., Marmocchi, F., Riva, F., Grifantini, M. J. Enzym. Inhib. (1985)
- Kinetic considerations for the regulation of adenosine and deoxyadenosine metabolism in mouse and human tissues based on a thymocyte model. Snyder, F.F., Lukey, T. Biochim. Biophys. Acta (1982)